Syros Pharmaceuticals News - SYRS

Company Name	Stock Ticker Symbol	Market	Type
Syros Pharmaceuticals Inc	SYRS	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	-0.18	-3.81%	4.54	19:56:39

Open Price	Low Price	High Price	Close Price	Prev Close
4.70	4.40	4.72	4.54	4.72

more quote information »

Recent News

Date	Time	Source	Heading
4/09/2024	07:00	BW	Syros Receives Fast Track Designation from the FDA for..
4/02/2024	16:30	BW	Syros Reports Inducement Grants Under Nasdaq Listing Rule..
3/27/2024	07:30	BW	Syros Reports Fourth Quarter and Full Year 2023 Financial..
3/27/2024	06:57	IHMARKETNEWS	U.S. Stock Index Futures Point to a Rebound, Oil See..
3/25/2024	07:00	BW	Syros Announces Completion of Enrollment of 190 Patients..
3/20/2024	07:00	BW	Syros to Report Fourth Quarter and Full Year 2023 Financial..
2/27/2024	07:00	BW	Syros to Participate in TD Cowen 44th Annual Health Care..
2/14/2024	20:56	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
2/13/2024	20:22	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2/13/2024	19:02	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2/13/2024	18:59	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
1/08/2024	07:06	EDGAR2	Form 8-K - Current report
1/08/2024	07:00	BW	Syros Highlights Anticipated 2024 Milestones to Deliver on..
1/02/2024	16:15	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
12/26/2023	17:19	EDGAR2	Form SC 13D/A - General statement of acquisition of..
12/19/2023	16:59	EDGAR2	Form 8-K - Current report
12/19/2023	16:53	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
12/19/2023	07:27	BW	Syros Announces Pricing of $45.0 million Underwritten..
12/14/2023	16:24	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/12/2023	16:12	EDGAR2	Form 144 - Report of proposed sale of securities
12/08/2023	16:23	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/06/2023	16:00	EDGAR2	Form 144 - Report of proposed sale of securities
12/06/2023	07:05	EDGAR2	Form 8-K - Current report
12/06/2023	07:00	BW	Syros Announces Encouraging Initial Data from Randomized..
12/05/2023	17:28	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/21/2023	07:30	BW	Syros to Participate in Upcoming Investor Conferences
11/14/2023	07:30	BW	Syros Reports Third Quarter 2023 Financial Results and..
11/14/2023	06:47	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/07/2023	07:30	BW	Syros to Report Third Quarter 2023 Financial Results on..
11/02/2023	16:53	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/02/2023	16:52	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/02/2023	16:52	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/02/2023	16:51	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/20/2023	16:15	EDGAR2	Form SC 13D - General statement of acquisition of beneficial..
10/02/2023	08:49	EDGAR2	Form 8-K - Current report
10/02/2023	08:45	BW	Syros Announces Planned CEO Leadership Transition and..
9/07/2023	16:30	BW	Syros Reports Inducement Grants Under Nasdaq Listing Rule..
8/11/2023	16:30	EDGAR2	Form 8-K - Current report
8/08/2023	07:30	BW	Syros Reports Second Quarter 2023 Financial Results and..
8/08/2023	06:53	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/04/2023	16:30	BW	Syros Reports Inducement Grants Under Nasdaq Listing Rule..
8/02/2023	16:21	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/01/2023	07:30	BW	Syros to Report Second Quarter 2023 Financial Results on..
7/31/2023	16:12	EDGAR2	Form 144 - Report of proposed sale of securities
7/21/2023	16:36	EDGAR2	Form 8-K - Current report
7/18/2023	20:27	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/17/2023	16:00	EDGAR2	Form 144 - Report of proposed sale of securities
7/05/2023	16:30	BW	Syros Reports Inducement Grants Under Nasdaq Listing Rule..
6/08/2023	07:30	BW	Syros to Present at Sidoti June 2023 Virtual Small-Cap..
6/01/2023	16:30	BW	Syros Reports Inducement Grants Under Nasdaq Listing Rule..